146 related articles for article (PubMed ID: 3932046)
1. Misoprostol clinical pharmacology. Establishment of activity in man.
Steiner JA
Dig Dis Sci; 1985 Nov; 30(11 Suppl):136S-141S. PubMed ID: 3932046
[TBL] [Abstract][Full Text] [Related]
2. Dose-response, meal-stimulated gastric antisecretory study of prostaglandin E1 analog, misoprostol, in man.
Davis GR; Fordtran JS; Dajani EZ
Dig Dis Sci; 1988 Mar; 33(3):298-302. PubMed ID: 3125026
[TBL] [Abstract][Full Text] [Related]
3. Perspective on the gastric antisecretory effects of misoprostol in man.
Dajani EZ
Prostaglandins; 1987; 33 Suppl():68-77. PubMed ID: 3122277
[TBL] [Abstract][Full Text] [Related]
4. Overview of misoprostol clinical experience.
Herting RL; Nissen CH
Dig Dis Sci; 1986 Feb; 31(2 Suppl):47S-54S. PubMed ID: 3080288
[TBL] [Abstract][Full Text] [Related]
5. Comparative inhibition of coffee-induced gastric acid secretion employing misoprostol and cimetidine.
Salmon PR; Barton T
Dig Dis Sci; 1986 Feb; 31(2 Suppl):55S-62S. PubMed ID: 3080289
[TBL] [Abstract][Full Text] [Related]
6. A double-blind placebo-controlled comparison of the efficacy and safety of 50, 100, and 200 micrograms of misoprostol QID in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms.
Lanza FL; Fakouhi D; Rubin A; Davis RE; Rack MF; Nissen C; Geis S
Am J Gastroenterol; 1989 Jun; 84(6):633-6. PubMed ID: 2499187
[TBL] [Abstract][Full Text] [Related]
7. Effects of misoprostol on gastric acid and mucus secretion in man.
Wilson DE; Quadros E; Rajapaksa T; Adams A; Noar M
Dig Dis Sci; 1986 Feb; 31(2 Suppl):126S-129S. PubMed ID: 3080283
[TBL] [Abstract][Full Text] [Related]
8. Marked suppression of stimulated gastric acid and pepsin secretion by enisoprost, a new PGE1 analogue.
Howden CW; Burget DW; Silletti C; Van Eeden A; Tomkins KB; Hunt RH
Aliment Pharmacol Ther; 1987 Aug; 1(4):305-13. PubMed ID: 2979675
[TBL] [Abstract][Full Text] [Related]
9. Gastric protection by misoprostol against 1300 mg of aspirin. An endoscopic study.
Silverstein FE; Kimmey MB; Saunders DR; Levine DS
Dig Dis Sci; 1986 Feb; 31(2 Suppl):137S-141S. PubMed ID: 3080286
[TBL] [Abstract][Full Text] [Related]
10. Healing of benign gastric ulcer. A placebo-controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E1.
Agrawal NM; Saffouri B; Kruss DM; Callison DA; Dajani EZ
Dig Dis Sci; 1985 Nov; 30(11 Suppl):164S-170S. PubMed ID: 3932050
[TBL] [Abstract][Full Text] [Related]
11. Antisecretory and mucosal protective actions of misoprostol. Potential role in the treatment of peptic ulcer disease.
Wilson DE
Am J Med; 1987 Jul; 83(1A):2-8. PubMed ID: 3113241
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal cytoprotective effects of misoprostol. Clinical efficacy overview.
Dajani EZ; Nissen CH
Dig Dis Sci; 1985 Nov; 30(11 Suppl):194S-200S. PubMed ID: 3932054
[TBL] [Abstract][Full Text] [Related]
13. Misoprostol, a synthetic PGE1 analog, in the treatment of duodenal ulcers. A multicenter double-blind study.
Brand DL; Roufail WM; Thomson AB; Tapper EJ
Dig Dis Sci; 1985 Nov; 30(11 Suppl):147S-158S. PubMed ID: 3932048
[TBL] [Abstract][Full Text] [Related]
14. Gastric protection by misoprostol against 1,300 mg of aspirin. An endoscopic dose-response study.
Silverstein FE; Kimmey MB; Saunders DR; Surawicz CM; Willson RA; Silverman BA
Am J Med; 1987 Jul; 83(1A):32-6. PubMed ID: 3113243
[TBL] [Abstract][Full Text] [Related]
15. Effects of the synthetic PGE1 derivative misoprostol on basal, stimulated and nocturnal acid secretion in duodenal ulcer cases. Mechanism of action.
Buzás G; Puscas I; Persa F; Reznicek A
Acta Physiol Hung; 1989; 73(2-3):185-91. PubMed ID: 2512765
[TBL] [Abstract][Full Text] [Related]
16. Effect of misoprostol on histamine-stimulated acid secretion and cyclic AMP formation in isolated canine parietal cells.
Tsai BS; Kessler LK; Butchko GM; Bauer RF
Dig Dis Sci; 1987 Sep; 32(9):1010-6. PubMed ID: 3040357
[TBL] [Abstract][Full Text] [Related]
17. Does misoprostol given as a single large dose improve its antisecretory effect?
Chiverton SG; Burget DW; Salena BJ; Hunt RH
Aliment Pharmacol Ther; 1989 Aug; 3(4):403-7. PubMed ID: 2518855
[TBL] [Abstract][Full Text] [Related]
18. Overview of clinical safety with misoprostol.
Herting RL; Clay GA
Dig Dis Sci; 1985 Nov; 30(11 Suppl):185S-193S. PubMed ID: 3932053
[TBL] [Abstract][Full Text] [Related]
19. Misoprostol preclinical pharmacology.
Bauer RF
Dig Dis Sci; 1985 Nov; 30(11 Suppl):118S-125S. PubMed ID: 3932042
[TBL] [Abstract][Full Text] [Related]
20. Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.
Monk JP; Clissold SP
Drugs; 1987 Jan; 33(1):1-30. PubMed ID: 3102205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
